Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence. [electronic resource]
- Clinical rheumatology Jan 2013
- 141-7 p. digital
Publication Type: Case Reports; Journal Article; Review; Systematic Review
1434-9949
10.1007/s10067-012-2105-2 doi
Antibodies, Monoclonal, Humanized--therapeutic use Antirheumatic Agents--therapeutic use Drug Resistance Drug Substitution Female Humans Middle Aged Remission Induction Still's Disease, Adult-Onset--drug therapy Treatment Outcome Young Adult